Yuemei Jin

678 citations
18 papers · 436 indexed · h-index 11
Topics
MicroRNA in disease regulation (4 papers)Cancer-related molecular mechanisms research (4 papers)Circular RNAs in diseases (3 papers)
Partner nations
ChinaUnited Kingdom

In The Last Decade

Yuemei Jin

16 papers receiving 430 citations

Peers

Yuemei Jin
Comparison fields: 5 of 72
  • Molecular Biology 322
  • Cancer Research 180
  • Oncology 76
  • Obstetrics and Gynecology 44
  • Immunology 39
Replace Marjaneh Farazestanian with:
Marjaneh Farazestanian Iran
Qiaohong Qin China
Aki Miyasaka Japan
Susanne Schüler‐Toprak Germany
Samina Dongol China
Qinyang Xu China
Georgios Tsatsaris Greece
Xiugui Sheng China
Sareena Singh United States
Yukihiro Hirata Japan
Yuemei Jin relative to Marjaneh Farazestanian Iran Marjaneh Farazestanian's profile →
Citations per field
00.5×3.5×
Marjaneh Farazestanian · 1×
Citations per year

Countries citing papers authored by Yuemei Jin

Since Specialization
Citations

This map shows the geographic impact of Yuemei Jin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yuemei Jin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yuemei Jin more than expected).

Fields of papers citing papers by Yuemei Jin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yuemei Jin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yuemei Jin. The network helps show where Yuemei Jin may publish in the future.

Co-authorship network of co-authors of Yuemei Jin

This figure shows the co-authorship network connecting the top 25 collaborators of Yuemei Jin. A scholar is included among the top collaborators of Yuemei Jin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yuemei Jin. Yuemei Jin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
#WorkIndexed citations
1 0
2 0
3 3
4 20
5 1
6 29
7 25
8 91
9 40
10 40
11 11
12
MIR-92 stimulates VEGF by inhibiting von Hippel-Lindau gene product in epithelial ovarian cancer.
9
13 38
14 6
15 56
16 48
17 17
18 2

About Yuemei Jin

Yuemei Jin is a scholar working on Cancer Research, Geriatrics and Gerontology and Immunology, having authored 18 papers that have together received 436 indexed citations. Recurring topics across this work include MicroRNA in disease regulation (4 papers), Cancer-related molecular mechanisms research (4 papers) and Circular RNAs in diseases (3 papers). The work is most often cited by research in Cancer Research (180 citations), Obstetrics and Gynecology (44 citations) and Molecular Biology (322 citations). Yuemei Jin has collaborated with scholars based in China and United Kingdom. Frequent co-authors include Tianmin Xu, Ling Wang, Fei Wu, Shanshan Liu, Li Fu, Fengjun Guo, Yichao Wang, Manhua Cui, Manhua Cui and Yan Zha. Their work appears in journals such as PLoS ONE, Experimental Cell Research and Life Sciences.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026